Statins increase risk of diabetes in Caucasian men
the ONA take:
According to new research published in the journal Diabetologia, researchers from Finland have found that statin use is associated with an increased risk of developing diabetes.
In the study, researchers analyzed data from 8,749 non-diabetic men in a 6-year follow-up of the population-based Metabolic Syndrome in Men (METSIM) study in Finland.
The participants ranged in age from 45 to 73 years and were followed for 5.9 years. Of those men, 625 were diagnosed with new diabetes during the follow-up period.
Results showed that after adjusting for confounding factors, patients treated with statins were 46% more likely to develop diabetes compared with those non treated with statins. In addition, researchers found that the risk was dose-dependent for atorvastatin and simvastatin.
The authors suggest that the association between statin use and increased risk for diabetes is most likely due to statins decreasing both insulin sensitivity and insulin secretion.
Although the findings are reliable, the study only included Caucasian men and therefore should not be applied to women or people of other ethnic origin without further research.
Statin use is associated with an increased risk of developing diabetes.
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Colorectal Cancer Rates Increased Sharply Among Generation X and Millennials
- Pneumonia Associated With Common Cold May Cause Fatal Illness in Stem Cell Transplant Recipients
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- Antiperspirants/Deodorants and Breast Cancer (Fact Sheet)
- Genome Sequencing Explains Resistance to CTLA-4 and PD-1 Inhibitors in Metastatic Melanoma
- Lifestyle Choices Have Greater Influence on Colon and Rectal Cancer Risk
- Kidney Cancer Metastases in Lung May Hide Undiagnosed Primary Lung Cancer
- Nasal Biomarker in Smokers Could Predict Lung Cancer
- Arm Lymphoscintigraphy After Axillary Lymph Node Dissection or Sentinel Lymph Node Biopsy in Breast Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|